Published in Hypertension on June 01, 1994
The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest (1996) 2.46
The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest (1997) 2.05
Bradykinin acutely inhibits activity of the epithelial Na+ channel in mammalian aldosterone-sensitive distal nephron. Am J Physiol Renal Physiol (2011) 1.06
In situ microdialysis in bone tissue. Stimulation of prostaglandin E2 release by weight-bearing mechanical loading. J Clin Invest (1996) 1.06
In vivo regulation of renal expression of (pro)renin receptor by a low-sodium diet. Am J Physiol Renal Physiol (2012) 0.93
Salt-dependent inhibition of epithelial Na+ channel-mediated sodium reabsorption in the aldosterone-sensitive distal nephron by bradykinin. Hypertension (2012) 0.90
Endogenous endothelins mediate increased distal tubule acidification induced by dietary acid in rats. J Clin Invest (1997) 0.88
Blockade of renal medullary bradykinin B2 receptors increases tubular sodium reabsorption in rats fed a normal-salt diet. Am J Physiol Renal Physiol (2008) 0.81
Direct regulation of ENaC by bradykinin in the distal nephron. Implications for renal sodium handling. Curr Opin Nephrol Hypertens (2014) 0.80
Vascular kinin B(1) and B(2) receptor-mediated effects in the rat isolated perfused kidney - differential regulations. Br J Pharmacol (1999) 0.78
Interaction of the renin angiotensin and cox systems in the kidney. Front Biosci (Schol Ed) (2016) 0.75
Angiotensin type 1 receptor mediates renal production and conversion of prostaglandins E2 to F2α in conscious diabetic rats. J Renin Angiotensin Aldosterone Syst (2015) 0.75
CB2 cannabinoid receptor-mediated peripheral antinociception. Pain (2001) 2.38
Kinins stimulate net chloride secretion by the rat colon. Br J Pharmacol (1982) 2.26
Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight-year follow-up. Circulation (1978) 1.75
Studies on lead exposure in patients of a neighborhood health center: Part I. Pediatric patients. J Natl Med Assoc (1991) 1.55
Graves' disease after 131I therapy for toxic nodule. Thyroid (2001) 1.50
Mediators of the secretory response to kinins. Br J Pharmacol (1984) 1.49
Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins. J Biol Chem (1984) 1.44
The radioimmunoassay of human urinary kallikrein and comparisons with kallikrein activity measurements. J Clin Endocrinol Metab (1980) 1.39
Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids. Circ Res (1974) 1.31
The effects of injected norepinephrine and sympathetic nerve stimulation in hypothyroid and hyperthyroid dogs. J Pharmacol Exp Ther (1965) 1.29
Orthostatic hypotension: mechanisms and management. Am Heart J (1975) 1.29
Isozymes of rat urinary kallikrein. Biochem Pharmacol (1979) 1.27
Urinary kallikrein excretion in normal man. Relationships to sodium intake and sodium-retaining steroids. Circ Res (1974) 1.25
Inhibition of short-circuit current in toad urinary bladder by inhibitors of glandular kallikrein. Am J Physiol (1980) 1.20
Malaria in the first 6 months of life in urban African infants with anemia. Am J Trop Med Hyg (2001) 1.19
Renin-angiotensin system modulates renal bradykinin production. Am J Physiol (1996) 1.18
Idiopathic orthostatic hypotension: circulatory dynamics in chronic autonomic insufficiency. Am J Cardiol (1974) 1.16
Molecular biology of tissue kallikrein. Biochem J (1988) 1.13
Effects of mineralocorticoids, altered sodium intake, and adrenalectomy on urinary kallikrein in rats. Circ Res (1972) 1.08
Role of calcium ions in kinin-induced chloride secretion. Br J Pharmacol (1984) 1.08
Identification of a new tissue-kallikrein-binding protein. Biochem J (1986) 1.08
Identification of tissue kallikrein in brain and in the cell-free translation product encoded by brain mRNA. J Biol Chem (1983) 1.05
Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide. Hypertension (1997) 1.04
Altered urinary kallikrein excretion in rats with hypertension. Circ Res (1972) 1.01
Kallikrein localization in rodent salivary glands and kidney with the immunoglobulin-enzyme bridge technique. J Histochem Cytochem (1979) 1.00
Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia (1982) 0.99
Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects. Ann Intern Med (1977) 0.99
Kinin effects on chloride secretion do not require eicosanoid synthesis. Br J Pharmacol (1984) 0.99
Differential effects of testosterone, thyroxine, and cortisol on rat submandibular gland versus renal kallikrein. Endocrinology (1983) 0.98
Teratogen-induced eye defects mediated by p53-dependent apoptosis. Curr Biol (1996) 0.97
The kallikrein-kinin system and the kidney. Annu Rev Physiol (1984) 0.96
Urinary kallikrein excretion in hypertension. Circ Res (1972) 0.96
Stimulation of renal interstitial bradykinin by sodium depletion. Am J Hypertens (1993) 0.96
A direct radioimmunoassay of rat urinary kallikrein and comparison with other measures of urinary kallikrein activity. J Lab Clin Med (1979) 0.96
Living conditions of children at risk for noma: Nigerian experience. Oral Dis (1999) 0.96
Urinary kallikrein excretion in spontaneously hypertensive rats. Circ Res (1975) 0.95
The value of electroencephalography in the diagnosis of subacute sclerosing panencephalitis. Dev Med Child Neurol (1974) 0.93
Amiloride inhibits mammalian renal kallikrein and a kallikrein-like enzyme from toad bladder and skin. J Clin Invest (1980) 0.92
Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: role of TGF-beta and MAPK. Am J Physiol Heart Circ Physiol (2000) 0.92
Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes. Am J Epidemiol (1976) 0.92
Urinary kallikrein in dogs with constriction of one renal artery. Proc Soc Exp Biol Med (1976) 0.92
Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man. J Clin Endocrinol Metab (1978) 0.91
Sex steroid hormones are altered in essential hypertension. J Hypertens (1989) 0.91
Kallikrein activation of a high molecular weight atrial peptide. Biochem Biophys Res Commun (1984) 0.91
Studies on rat renal cortical cell kallikrein. II. Identification of kallikrein as an ecto-enzyme. Biochim Biophys Acta (1979) 0.90
Plasma mineralocorticoids, plasma renin, and urinary kallikrein in salt-sensitive and salt-resistant rats. Endocr Res Commun (1978) 0.90
Kallikrein-induced uterine contraction independent of kinin formation. Proc Natl Acad Sci U S A (1981) 0.90
Effect of ingestion of meat on plasma cholesterol of vegetarians. JAMA (1981) 0.89
Activation of MAPK by modified low-density lipoproteins in vascular smooth muscle cells. J Appl Physiol (1985) (2001) 0.89
Tryptase and kinin generation: tryptase from human mast cells does not activate human urinary prokallikrein. Int Arch Allergy Appl Immunol (1987) 0.89
Isolation of tissue kallikrein in rat spleen by monoclonal antibody-affinity chromatography. Biochim Biophys Acta (1984) 0.89
Blood pressure responses to care procedures in ventilated preterm infants. Acta Paediatr Scand (1985) 0.89
Urinary kallikrein in hypertensive animal models. Fed Proc (1976) 0.89
Electrocardiogram in evaluation of resistance to antihypertensive therapy. Arch Intern Med (1977) 0.88
Identification and characterization of a tissue kallikrein in rat skeletal muscles. Biochem J (1987) 0.88
Relationship between skin color and blood pressure in egyptian adults: results from the national hypertension project. Hypertension (2000) 0.88
Tissue kallikrein in rat brain and pituitary: regional distribution and estrogen induction in the anterior pituitary. Endocrinology (1987) 0.88
Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells. Diabetes (2000) 0.87
Role of reactive oxygen species in bradykinin-induced mitogen-activated protein kinase and c-fos induction in vascular cells. Hypertension (2000) 0.87
Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol (1999) 0.87
Bradykinin B2 receptor antagonist increases chloride and water absorption in rat medullary collecting duct. Am J Physiol (1996) 0.87
Specific identification of tissue kallikrein in exocrine tissues and in cell-free translation products with monoclonal antibodies. Biochem J (1985) 0.87
Renal excretion of kallikrein and eicosanoids in patients with type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function. Diabetologia (1992) 0.87
Risperidone-induced increase of plasma norepinephrine is not correlated with symptom improvement in chronic schizophrenia. Biol Psychiatry (1999) 0.87
Relationships among urinary kallikrein, mineralocorticoids and human hypertensive disease. Fed Proc (1976) 0.86
Human plasma inactive renin: purification and activation by proteases. J Clin Endocrinol Metab (1982) 0.86
Immunocytochemical localization of tissue kallikrein in brain ventricular epithelium and hypothalamic cell bodies. J Histochem Cytochem (1985) 0.86
Tissue kallikrein synthesis and its modification by testosterone or low dietary sodium. Biochem J (1984) 0.86
Bradykinin B2 receptors activate Na+/H+ exchange in mIMCD-3 cells via Janus kinase 2 and Ca2+/calmodulin. J Biol Chem (2001) 0.85
Oleic acid and angiotensin II induce a synergistic mitogenic response in vascular smooth muscle cells. Hypertension (1998) 0.85
Effect of renal transplantation of uraemic neuropathy. Lancet (1974) 0.85
Regulation of B(2)-kinin receptors by glucose in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2001) 0.84
Characterization of monoclonal and polyclonal antibodies to human tissue kallikrein. Hypertension (1986) 0.83
Immunoreactive tissue kallikrein in human serum. J Lab Clin Med (1984) 0.83
Safety and feasibility of dobutamine-atropine stress testing in hypertensive patients. Hypertension (1997) 0.83
Maintenance of normocalcemia by continuous infusion of the synthetic bovine parathyroid hormone (1-34) in parathyroidectomized rats. Calcif Tissue Int (1982) 0.83
Dobutamine 99Tcm-MIBI SPET myocardial perfusion scintigraphy in the prediction of restenosis after percutaneous transluminal coronary angioplasty in patients unable to perform an exercise stress test. Nucl Med Commun (1997) 0.83
Myocardial perfusion abnormalities in treated hypertensive patients without known coronary artery disease. J Hypertens (1999) 0.82
Skeletal muscle kallikrein. Potential role in metabolic regulation. Diabetes (1996) 0.82
Hemodynamic characteristics of primary aldosteronism. N Engl J Med (1973) 0.82
The effects of aldosterone and spironolactone on renal kallikrein in the rat. Clin Sci Mol Med Suppl (1976) 0.82
The Egyptian National Hypertension Project (NHP). Design and rationale. The NHP Investigative Team. Hypertension (1995) 0.82
Cellular distribution of exogenous aprotinin in the rat kidney. Biol Chem (1998) 0.82
Famine in Somalia. Lancet (1993) 0.81
Effect of gonadal steroid hormones on the metabolic rate of the cold-acclimated gonadectomized male and female Chalcides ocellatus (Forskal). Gen Comp Endocrinol (1990) 0.81
Measurement of glomerular filtration rate and renal plasma flow in the diabetic rat by the single-injection isotopic technique: effects of altered distribution volumes of 51Cr-EDTA and 125I-hippuran. Diabetes Res (1988) 0.81
Bcl-2 relieves deoxyadenylate stress and suppresses apoptosis in pre-B leukemia cells. Cell Death Differ (1995) 0.81
Renal kallikrein and hemodynamic abnormalities of diabetic kidney. Diabetes (1990) 0.81
Serum ferritin and other haematological measurements in apparently healthy adults with malaria parasitaemia in Lagos, Nigeria. Trop Med Int Health (2000) 0.81
Studies on the origin of human hypertension. Postgrad Med J (1977) 0.81
Localization of lesion in patients with idiopathic orthostatic hypotension. Br Heart J (1975) 0.81
A quantitative study of the levels of glandular kallikrein in normal and diabetic rats. Biochem Med (1984) 0.81
Renal kallikrein-kinin system. Relation to renal function and blood pressure. Am J Nephrol (1983) 0.81
Insulin and arachidonic acid metabolism in diabetes mellitus. Metabolism (1985) 0.81
The functional significance of chronotropic incompetence during dobutamine stress test. Heart (1999) 0.81